Industry Report

OTC market in Poland 2021

Market analysis and development forecasts for 2021-2026

This product is also available in Polish

OTC market in Poland 2021

Market analysis and development forecasts for 2021-2026

Infographic Brochure Index and sample pages
Other versions: Polish
Sector: OTC
Country: Poland

An analysis of the OTC market prepared by PMR experts presents the current market situation, growth forecasts, market value and structure, as well as important legal regulations, trends and events that will have an impact on the OTC segment in the years 2021-2026. An important part of the report contains data on sales of non-pharmacy and online OTC drugs and dietary supplements, as well as forecasts for the main categories of OTC drugs and dietary supplements until 2026.

The current edition also includes analyses of the impact of the coronavirus pandemic on the market. It discusses in detail such phenomena as: mass buy-out of medicines and dietary supplements, development of alternative sales channels as well as forecasts until 2026, prepared taking into account the epidemiological situation in Poland and worldwide.

Content

What is the content of the report?

  • Extensive analysis with growth forecasts to 2026 for the entire OTC market, including: OTC drugs, dietary supplements, pharmacy sales, non-pharmacy sales
  • Including the impact of the coronavirus epidemic and the latest macroeconomic forecasts prepared by PMR econometricians
  • Extensive database of OTC market data
  • Characteristics of product distribution channels
  • Consumer and producer segment trends influencing the market situation and development
  • Examples of changes in the Rx-OTC and OTC-Rx switch over the last few years
  • List of best-selling OTC drugs and dietary supplements
  • Detailed profiles of major players on the market
  • Analysis of OTC product advertising across all major communication channels
  • Impact of COVID-19 on shopping habits and other consumer behaviours and preferences based on PMR's own research
  • A description of the latest and planned legal regulations affecting the market
Benefits

Why to buy the report?

  • The only such report in Poland. 16 years of experience and analysis of the OTC market.
  • Expert assessment of the impact of events and trends on the market until 2026
  • Detailed forecasts prepared taking into account the global epidemiological situation.
  • Presented sales data verified by analysts.
  • Results of PMR consumer survey on the impact of the coronavirus pandemic on OTC product purchases.
Users

Who benefits from the analysis?

Management representatives and decision makers from marketing, sales and business development representing:

  • manufacturers of OTC drugs and dietary supplements as well as other parapharmaceuticals,
  • companies specialising in the pharmacy sales of OTC drugs and dietary supplements as well as other parapharmaceuticals,
  • entities involved in online and non-pharmacy distribution of OTC products and dietary supplements in Poland,
  • advertising agencies operating in the pharmaceutical industry,
  • private equity funds, financial institutions,
  • research and academic institutions,
  • embassies, government and industry agencies, banks.
Table of Contents
  • Methodology
  • Executive summary

More info

For details on price and content please call:
+48 12 340 51 30
or email sales@pmrcorporate.com

Other versions: Polish
Sector: OTC
Country: Poland

Find out more!

Get index, sample pages and additional data:

Index and sample pages

Each licence option entitles Client to make use of the product within the following limits/ number of users:

Standard – up to 2 users

Standard Plus – between 3 and 9 users

Corporate – from 10 unique users and more

For more information please visit: mypmr.pro/terms-and-conditions

This content is available for current PMR clients. If you are a client please log-in or contact us for more information at: +48 12 340 51 30.

Jest to zawartość dostępna dla obecnych klientów PMR. Jeśli jesteś klientem, zaloguj się lub skontaktuj się z nami, aby uzyskać więcej informacji: +48 12 340 51 30.